News Detail
Indore, 5 Jan 2025: With the mandatory enforcement of the revised Schedule M manufacturing standards implemented from January 1, 2025, the Food and Drug Administration (FDA) department in collaboration with the Central Drugs Standard Control Organisation (CDSCO) has established a......
View Details
Source : The Times of India
Today news Indore
revised Schedule M compliance
pharmaceutical manufacturing standards
Indore pharmaceutical industry
Good Manufacturing Practices
FDA joint team
Related News
- IPC raises alarm on adverse reaction caused by Beta- blocker drugs (07-01-2025)
- Police launch probe into two infants’ deaths, kin blame vaccine (07-01-2025)
- 'HMPV does not spread like Covid-19': Expert debunks myths, explains precautions needed to combat virus (07-01-2025)
- Extension of revised Schedule M deadline fails to bring total relief to MSMEs (07-01-2025)
- IIT Guwahati Advances Cholesterol and Triglyceride detection with Advanced Nanotechnology (07-01-2025)
- FDA issues draft guidance on ensuring pulse oximeter accuracy (07-01-2025)
- Parliamentary panel to review CDSCO’s performance on checking spurious drugs (07-01-2025)
- FDA issues first draft guidance on the use of AI for the development of drug and biological products (07-01-2025)
- Falsified lab reports: Warangal district witnessing surge in unauthorised diagnostic centres (07-01-2025)
- First ayurvedic diagnostic device 'Nadi Tarangini', gets CDSCO nod (06-01-2025)